RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. EBITDA

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.4B
P/E ratio
12.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Sep 30, 20258,865+22.73%
Sep 30, 20247,223+10.02%
Sep 30, 20236,565+5.23%
Sep 30, 20226,239+20.51%
Sep 30, 20215,177+5.37%
Sep 30, 20204,913-18.43%
Sep 30, 20196,023-5.40%
Sep 30, 20186,367+4.67%
Sep 30, 20176,083+16.20%
Sep 30, 20165,235+4.30%
Sep 30, 20155,019+10.33%
Sep 30, 20144,549

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)